- Wondering if Afya's share price reflects its real worth, or if the market is missing something important about this education business.
- Afya's stock has recently closed at US$14.82, with returns of 9.8% over 7 days and 6.5% over 30 days, while the 1 year return sits at a 16.5% decline and the 3 year return at 50.7%.
- Recent coverage has focused on Afya's position within the Consumer Services sector and how investors are reassessing growth prospects versus risks in the education space. This context helps explain why shorter term gains sit alongside a 1 year decline, as sentiment can shift faster than the underlying business.
- Afya currently has a valuation score of 5 out of 6. The next sections will break down how different valuation methods arrive at that result, before finishing with a broader way to think about what this score really means for you.
Find out why Afya's -16.5% return over the last year is lagging behind its peers.
Approach 1: Afya Discounted Cash Flow (DCF) Analysis
A Discounted Cash Flow model takes the cash Afya is expected to generate in the future and then discounts those projections back to today to estimate what the business could be worth now.
For Afya, the model used is a 2 Stage Free Cash Flow to Equity approach. The latest twelve month Free Cash Flow is R$1,156.51m. Analyst input and Simply Wall St extrapolations project Free Cash Flow reaching R$1,463.13m in 2035, with interim projections such as R$1,134m in 2026 and R$1,164m in 2027. All of these future cash flows are discounted back to today and summed.
On this basis, the estimated intrinsic value comes out at US$32.08 per share, using Afya’s share price currency for the final result, even though the underlying cash flows are in R$. Compared to the recent share price of US$14.82, the model implies a 53.8% discount, which indicates Afya may be trading below this DCF estimate.
Result: UNDERVALUED
Our Discounted Cash Flow (DCF) analysis suggests Afya is undervalued by 53.8%. Track this in your watchlist or portfolio, or discover 49 more high quality undervalued stocks.
Approach 2: Afya Price vs Earnings
For a profitable company like Afya, the P/E ratio is a useful way to relate what you pay per share to the earnings that each share generates. It gives a quick sense of how much the market is willing to pay for current earnings.
What counts as a normal or fair P/E depends on how investors weigh two things: expected earnings growth and the level of risk around those earnings. Higher growth or lower perceived risk can support a higher P/E, while lower growth or higher risk usually calls for a lower multiple.
Afya currently trades on a P/E of 9.23x. That sits well below the Consumer Services industry average of 17.02x and the peer group average of 48.15x. Simply Wall St’s Fair Ratio for Afya is 16.86x, which is the P/E that would typically be expected given factors such as its earnings profile, industry, profit margins, market value and risk characteristics.
This Fair Ratio is more tailored than a simple comparison with peers or the industry because it adjusts for company specific traits rather than assuming one size fits all. With Afya’s actual P/E at 9.23x versus a Fair Ratio of 16.86x, the shares look undervalued on this metric.
Result: UNDERVALUED
P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 20 top founder-led companies.
Upgrade Your Decision Making: Choose your Afya Narrative
Earlier it was mentioned that there is an even better way to think about valuation, so meet Narratives: a simple way for you to connect your view of Afya’s story with hard numbers like future revenue, earnings, margins and an assumed fair value.
A Narrative is your version of the Afya story. For example, you might think Afya looks closer to the more cautious view with a fair value around US$14.42, or closer to the optimistic view with a fair value near US$25.62, and then tie that story to explicit assumptions about how fast revenue could grow, what profit margins might look like and what P/E feels reasonable.
On Simply Wall St, Narratives sit inside the Community page so you can quickly compare different fair values and stories from other investors and analysts, then line them up against the current Afya share price to help decide whether the stock looks expensive or cheap to you at any point in time.
Because Narratives update when new information appears, such as earnings releases, regulatory news or fresh analyst targets, your Afya view does not stay static. You can adjust your story and numbers and see instantly how that changes your estimated fair value and the gap to today’s price.
Do you think there's more to the story for Afya? Head over to our Community to see what others are saying!
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com